International Journal of Endocrinology and Metabolism

Published by: Kowsar

A Case Report of Thyroid Carcinoma Confined to Ovary and Concurrently Occult in the Thyroid: Is Conservative Treatment Always Advised?

Nunzia Brusca 1 , Susanna Carlotta Del Duca 1 , Rita Salvatori 2 , Antonio D’Agostini 2 , Pina Cannas 2 , Maria Giulia Santaguida 1 , Camilla Virili 1 , Loredana Bianchi 3 , Lucilla Gargano 3 and Marco Centanni 1 , 3 , *
Authors Information
1 Department of Medico-Surgical Sciences and Biotechnologies, “Sapienza” University of Rome, Latina, Italy
2 Department of Nuclear Medicine, Santa Maria Goretti Hospital, AUSL Latina, Latina, Italy
3 Endocrinology Unit, Santa Maria Goretti Hospital, AUSL Latina, Latina, Italy
Article information
  • International Journal of Endocrinology and Metabolism: January 01, 2015, 13 (1); e18220
  • Published Online: January 22, 2015
  • Article Type: Case Report
  • Received: February 17, 2014
  • Revised: April 22, 2014
  • Accepted: May 10, 2014
  • DOI: 10.5812/ijem.18220

To Cite: Brusca N, Del Duca S C, Salvatori R, D’Agostini A, Cannas P, et al. A Case Report of Thyroid Carcinoma Confined to Ovary and Concurrently Occult in the Thyroid: Is Conservative Treatment Always Advised?, Int J Endocrinol Metab. 2015 ;13(1):e18220. doi: 10.5812/ijem.18220.

Abstract
Copyright: Copyright © 0, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
Footnotes
References
  • 1. Kabukcuoglu F, Baksu A, Yilmaz B, Aktumen A, Evren I. Malignant struma ovarii. Pathol Oncol Res. 2002; 8(2): 145-7[PubMed]
  • 2. McGill JF, Sturgeon C, Angelos P. Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation. Endocr Pract. 2009; 15(2): 167-73[DOI][PubMed]
  • 3. Zhang X, Axiotis C. Thyroid-type carcinoma of struma ovarii. Arch Pathol Lab Med. 2010; 134(5): 786-91[DOI][PubMed]
  • 4. Salman WD, Singh M, Twaij Z. A case of papillary thyroid carcinoma in struma ovarii and review of the literature. Patholog Res Int. 2010; 2010: 352476[DOI][PubMed]
  • 5. Hatami M, Breining D, Owers RL, Del Priore G, Goldberg GL. Malignant struma ovarii--a case report and review of the literature. Gynecol Obstet Invest. 2008; 65(2): 104-7[DOI][PubMed]
  • 6. Yoo SC, Chang KH, Lyu MO, Chang SJ, Ryu HS, Kim HS. Clinical characteristics of struma ovarii. J Gynecol Oncol. 2008; 19(2): 135-8[DOI][PubMed]
  • 7. Jean S, Tanyi JL, Montone K, McGrath C, Lage-Alvarez MM, Chu CS. Papillary thyroid cancer arising in struma ovarii. J Obstet Gynaecol. 2012; 32(3): 222-6[DOI][PubMed]
  • 8. Barrera JR, Manalo LA, Ang FL. Papillary thyroid-type carcinoma arising from struma ovarii. BMJ Case Rep. 2012; 2012[DOI][PubMed]
  • 9. Alvarez DM, Lee V, Bhatt S, Dogra VS. Struma ovarii with papillary thyroid carcinoma. J Clin Imaging Sci. 2011; 1: 44[DOI][PubMed]
  • 10. Cibas ES, Ali SZ, N. C. I. Thyroid FNA State of the Science Conference . The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009; 132(5): 658-65[DOI][PubMed]
  • 11. Danese D, Centanni M, Farsetti A, Andreoli M. Diagnosis of thyroid carcinoma. J Exp Clin Cancer Res. 1997; 16(3): 337-47[PubMed]
  • 12. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006; 154(6): 787-803[DOI][PubMed]
  • 13. Meas T, Vercellino L, Faugeron I, Toubert ME. The 2009 revised American Thyroid Association guidelines for thyroid cancer: multifocality in T1 tumors in question, for or against a more minimalist approach? Thyroid. 2013; 23(8): 1042-3[DOI][PubMed]
  • 14. Marti JL, Clark VE, Harper H, Chhieng DC, Sosa JA, Roman SA. Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases. Thyroid. 2012; 22(4): 400-6[DOI][PubMed]
  • 15. Collins AM, Bodenner D, Chen C, Stone P, Stack BC, Jr.. Delayed treatment of papillary thyroid carcinoma arising from struma ovarii in a patient with history of bilateral salpingo-oophorectomy: a case report. Endocr Pract. 2012; 18(1)-4[DOI][PubMed]
  • 16. Coyne C, Nikiforov YE. RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii. Endocr Pathol. 2010; 21(2): 144-7[DOI][PubMed]
  • 17. Ardito G, Revelli L, Giustozzi E, Salvatori M, Fadda G, Ardito F, et al. Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy. Clin Nucl Med. 2013; 38(1): 25-8[DOI][PubMed]
  • 18. Janszen EW, van Doorn HC, Ewing PC, de Krijger RR, de Wilt JH, Kam BL, et al. Malignant struma ovarii: good response after thyroidectomy and I ablation therapy. Clin Med Oncol. 2008; 2: 147-52[PubMed]
  • 19. Sakorafas GH, Giotakis J, Stafyla V. Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat Rev. 2005; 31(6): 423-38[DOI][PubMed]
  • 20. American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, Cooper DS, Doherty GM, Haugen BR, Kloos RT, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19(11): 1167-214[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader